Hannonen P - Search Results

1

Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data.

Nikiphorou E, Kautiainen H, Hannonen P, Asikainen J, Kokko A, Rannio T, Sokka T. Nikiphorou E, et al. Among authors: hannonen p. Expert Opin Biol Ther. 2015;15(12):1677-83. doi: 10.1517/14712598.2015.1103733. Epub 2015 Nov 7. Expert Opin Biol Ther. 2015. PMID: 26549204

2

Survival and safety of infliximab bio-original and infliximab biosimilar (CT-P13) in usual rheumatology care.

Nikiphorou E, Hannonen P, Asikainen J, Borodina J, Kokko A, Paalanen K, Rannio T, Sokka T. Nikiphorou E, et al. Among authors: hannonen p. Clin Exp Rheumatol. 2019 Jan-Feb;37(1):55-59. Epub 2018 Jun 7. Clin Exp Rheumatol. 2019. PMID: 29998827

3

Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years.

Sokka T, Kautiainen H, Häkkinen A, Hannonen P. Sokka T, et al. Among authors: hannonen p. J Rheumatol. 2004 Jun;31(6):1073-82. J Rheumatol. 2004. PMID: 15170917

4

Frequency of remissions in early rheumatoid arthritis defined by 3 sets of criteria. a 5-year followup study.

Mäkinen H, Kautiainen H, Hannonen P, Sokka T. Mäkinen H, et al. Among authors: hannonen p. J Rheumatol. 2005 May;32(5):796-800. J Rheumatol. 2005. PMID: 15868611

5

Conventional disease-modifying antirheumatic drugs in early arthritis.

Sokka T, Hannonen P, Möttönen T. Sokka T, et al. Among authors: hannonen p. Rheum Dis Clin North Am. 2005 Nov;31(4):729-44. doi: 10.1016/j.rdc.2005.07.007. Rheum Dis Clin North Am. 2005. PMID: 16287594 Review.

6

Sokka T, Haugeberg G, Asikainen J, Widding Hansen IJ, Kokko A, Rannio T, Soldal DM, Hannonen P. Sokka T, et al. Among authors: hannonen p. Clin Exp Rheumatol. 2013 May-Jun;31(3):409-14. Epub 2013 Feb 15. Clin Exp Rheumatol. 2013. PMID: 23415074

7

Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis.

Rannio T, Asikainen J, Kokko A, Hannonen P, Sokka T. Rannio T, et al. Among authors: hannonen p. J Rheumatol. 2016 Apr;43(4):699-706. doi: 10.3899/jrheum.141480. Epub 2016 Feb 15. J Rheumatol. 2016. PMID: 26879355

8

Is long-term radiographic joint damage different between men and women? Prospective longitudinal data analysis of four early RA cohorts with greater than 15 years follow-up.

Asikainen J, Nikiphorou E, Kaarela K, Lindqvist E, Häkkinen A, Kautiainen H, Hannonen P, Rannio T, Sokka T. Asikainen J, et al. Among authors: hannonen p. Clin Exp Rheumatol. 2016 Jul-Aug;34(4):641-5. Epub 2016 Apr 28. Clin Exp Rheumatol. 2016. PMID: 27156863 Free article.

9

Long-term outcomes of destructive seronegative (rheumatoid) arthritis - description of four clinical cases.

Nikiphorou E, Sjöwall C, Hannonen P, Rannio T, Sokka T. Nikiphorou E, et al. Among authors: hannonen p. BMC Musculoskelet Disord. 2016 Jun 3;17:246. doi: 10.1186/s12891-016-1067-y. BMC Musculoskelet Disord. 2016. PMID: 27256084 Free PMC article.

10

Delivering a one-stop, integrated, and patient-centered service for patients with rheumatic diseases.

Väre P, Nikiphorou E, Hannonen P, Sokka T. Väre P, et al. Among authors: hannonen p. SAGE Open Med. 2016 Jun 14;4:2050312116654404. doi: 10.1177/2050312116654404. eCollection 2016. SAGE Open Med. 2016. PMID: 27437101 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters